Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Blood

• Publication date

  2008-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2007-08-105809PMID 17967940
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells.

  2008cited by this paper
• Murine bone marrow stromal progenitor cells elicit an in vivo cellular and humoral alloimmune response.

  2007cited by this paper
• Widespread Distribution and Muscle Differentiation of Human Fetal Mesenchymal Stem Cells After Intrauterine Transplantation in Dystrophic mdx Mouse

  2007cited by this paper
• Human First‐Trimester Fetal MSC Express Pluripotency Markers and Grow Faster and Have Longer Telomeres Than Adult MSC

  2007cited by this paper
• Experience With Bisphosphonates in Osteogenesis Imperfecta

  2007cited by this paper
• Distribution of Single‐Cell Expanded Marrow Derived Progenitors in a Developing Mouse Model of Osteogenesis Imperfecta Following Systemic Transplantation

  2007cited by this paper
• Enhanced In Vivo Homing of Uncultured and Selectively Amplified Cord Blood CD34+ Cells by Cotransplantation with Cord Blood‐Derived Unrestricted Somatic Stem Cells

  2007cited by this paper
• In utero stem cell transplantation.

  2006cited by this paper
• Characterization and Multipotentiality of Human Fetal Femur–Derived Cells: Implications for Skeletal Tissue Regeneration

  2006cited by this paper
• Progenitors Systemically Transplanted into Neonatal Mice Localize to Areas of Active Bone Formation In Vivo: Implications of Cell Therapy for Skeletal Diseases

  2006cited by this paper
• Fetal stem cells: betwixt and between.

  2006cited by this paper
• Comparison of Growth and Differentiation of Fetal and Adult Rhesus Monkey Mesenchymal Stem Cells

  2006cited by this paper
• Human Fetal Mesenchymal Stem Cells as Vehicles for Gene Delivery

  2005cited by this paper
• Growth Hormone Injections Improve Bone Quality in a Mouse Model of Osteogenesis Imperfecta

  2005cited by this paper
• Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells.

  2005cited by this paper
• Effects of Growth Hormone Transgene Expression on Vertebrae in a Mouse Model of Osteogenesis Imperfecta

  2005cited by this paper
• Fetal Mesenchymal Stem-Cell Engraftment in Bone after In Utero Transplantation in a Patient with Severe Osteogenesis Imperfecta

  2005cited by this paper
• Effects of T-lymphocyte depletion on muscle fibrosis in the mdx mouse.

  2005cited by this paper
• Mesenchymal Stem Cell Engraftment in Bone Following In Utero Transplantation in a Patient with Severe Osteogenesis Imperfecta.

  2004cited by this paper
• Fixation-induced redistribution of hyperphosphorylated RNA polymerase II in the nucleus of human cells.

  2004cited by this paper
• In utero stem cell transplantation.

  2004cited by this paper
• Osteogenesis imperfecta.

  2004cited by this paper
• Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy.

  2004cited by this paper
• A thyrotoxic skeletal phenotype of advanced bone formation in mice with resistance to thyroid hormone.

  2003cited by this paper
• Alendronate affects long bone length and growth plate morphology in the oim mouse model for Osteogenesis Imperfecta.

  2003cited by this paper
• Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone

  2002cited by this paper
• Engraftment of bone marrow and fetal liver cells after in utero transplantation in MDX mice.

  2002cited by this paper
• Alendronate Treatment for Infants with Osteogenesis Imperfecta: Demonstration of Efficacy in a Mouse Model

  2002cited by this paper
• A Controlled Study of the Effects of Alendronate in a Growing Mouse Model of Osteogenesis Imperfecta

  2001cited by this paper
• Receptor specificity in the self-renewal and differentiation of primary multipotential hemopoietic cells.

  2001cited by this paper
• Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta.

  2001cited by this paper
• Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow.

  2001cited by this paper
• Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep

  2000cited by this paper
• Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta

  1999cited by this paper
• Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta.

  1998cited by this paper
• Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta.

  1993cited by this paper
• Osteogenesis Imperfecta.

  year unknowncited by this paper

• Deep insights and clinical benefits from the comprehensive cohort of fetal skeletal dysplasia in China.

  2025cites this paper
• Mesenchymal Stem Cell Transplantation for Osteogenesis Imperfecta Patients: A Systematic Review

  2025cites this paper
• Engineering bone tissue with mRNA: from molecular design and delivery to clinical applications

  2025cites this paper
• Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies

  2025cites this paper
• Human second-trimester fetal liver-derived mesenchymal stromal cells are more effective than adult bone marrow MSCs for their superior growth kinetics, immunomodulatory, and osteogenic potential.

  2025cites this paper
• Pleiotropic effects of a recessive Col1a2 mutation occurring in a mouse model of severe osteogenesis imperfecta

  2025cites this paper
• The Role of Mitochondrial Homeostasis in Mesenchymal Stem Cell Therapy—Potential Implications in the Treatment of Osteogenesis Imperfecta

  2024cites this paper
• Emerging Landscape of Osteogenesis Imperfecta Pathogenesis and Therapeutic Approaches.

  2024cites this paper
• New Perspectives of Therapies in Osteogenesis Imperfecta—A Literature Review

  2024cites this paper
• Mesenchymal stem cells in the treatment of osteogenesis imperfecta

  2023cites this paper
• Developmental potency of human ES cell-derived mesenchymal stem cells revealed in mouse embryos following blastocyst injection.

  2023cites this paper
• Innovations in cell therapy in pediatric diseases: a narrative review

  2023cites this paper
• Experimental and clinical progress of in utero hematopoietic cell transplantation therapy for congenital disorders

  2022cites this paper
• Murine Animal Models in Osteogenesis Imperfecta: The Quest for Improving the Quality of Life

  2022cites this paper
• Mesencyhmal Stem Cell Therapy for Osteogenesis Imperfect.

  2021cites this paper
• Systemic Supplementation of Collagen VI by Neonatal Transplantation of iPSC-Derived MSCs Improves Histological Phenotype and Function of Col6-Deficient Model Mice

  2021cites this paper
• Modification of COL1A1 in Autologous Adipose Tissue‐Derived Progenitor Cells Rescues the Bone Phenotype in a Mouse Model of Osteogenesis Imperfecta

  2021cites this paper
• Osteogenesis Imperfecta: Mechanisms and signaling pathways connecting classical and rare OI types.

  2021cites this paper
• Osteogenesis imperfecta and other defects of bone development as occasional causes of adult osteoporosis

  2021cites this paper
• A systematic review and meta-analysis on the efficacy of stem cell therapy on bone brittleness in mouse models of osteogenesis imperfecta

  2021cites this paper
• Hematopoietic stem cell‐derived functional osteoblasts exhibit therapeutic efficacy in a murine model of osteogenesis imperfecta

  2020cites this paper
• Stem Cell Therapy as a Treatment for Osteogenesis Imperfecta

  2020cites this paper
• Mesenchymal stem cells: amazing remedies for bone and cartilage defects

  2020cites this paper
• Application of Tissue Engineering and Regenerative Medicine in Maternal-Fetal Medicine.

  2020cites this paper
• Osteogenesis Imperfecta: A Heterogeneous Heritable Disease

  2019cites this paper
• In Utero Cell Transplantation as a Tool for Fixing Liver-based Inherited Metabolic Disorders: Early Technical Evidence Supporting Potential Feasibility.

  2019cites this paper
• Application of a Bioactive/Bioresorbable Three-Dimensional Porous Uncalcined and Unsintered Hydroxyapatite/Poly-d/l-lactide Composite with Human Mesenchymal Stem Cells for Bone Regeneration in Maxillofacial Surgery: A Pilot Animal Study

  2019cites this paper
• Characterising the heterogeneity of human mid-trimester amniotic fluid stem cells

  2019cites this paper
• Stem cells in Osteoporosis: From Biology to New Therapeutic Approaches

  2019cites this paper
• Prenatal stem cell therapy for inherited diseases: Past, present, and future treatment strategies

  2019cites this paper
• CXCR4-Overexpressing Umbilical Cord Mesenchymal Stem Cells Enhance Protection against Radiation-Induced Lung Injury

  2019cites this paper
• Engraftment of skeletal progenitor cells by bone‐directed transplantation improves osteogenesis imperfecta murine bone phenotype

  2019cites this paper
• Transcriptionally distinct mesenchymal stem/stromal cells circulate in fetus.

  2019cites this paper
• Fetal stem cell transplantation and gene therapy.

  2019cites this paper
• Understanding and Modulating Bone and Cartilage Cell Fate for Regenerative Medicine

  2019cites this paper
• Heritable Skeletal Disorders Arising from Defects in Processing and Transport of Type I Procollagen from the ER: Perspectives on Possible Therapeutic Approaches.

  2018cites this paper
• Fetal Mesenchymal Stromal Cells: an Opportunity for Prenatal Cellular Therapy

  2018cites this paper
• Tissue Engineering and Cell-Based Therapies for Fractures and Bone Defects

  2018cites this paper
• Osteogenesis imperfecta and therapeutics.

  2018cites this paper
• Sacralizaciones artísticas en los autos sacramentales de Lope. El caso de La puente del mundo

  2018cites this paper
• Targeting Trafficking in Drug Development

  2018cites this paper
• Bone Marrow Transplantation for Treatment of the Col1a2+/G610C Osteogenesis Imperfecta Mouse Model

  2018cites this paper
• Effects of Bone Marrow Stromal Cell Transplantation on Repair of Bone Defect in Rats

  2018cites this paper
• The Effect of Scaffold Modulus on the Morphology and Remodeling of Fetal Mesenchymal Stem Cells

  2018cites this paper
• Embryonic Stem Cell‐Derived Mesenchymal Stem Cells (MSCs) Have a Superior Neuroprotective Capacity Over Fetal MSCs in the Hypoxic‐Ischemic Mouse Brain

  2018cites this paper
• Chapter 23 – Osteogenesis Imperfecta

  2018cites this paper
• Bone repair potential of human amniotic fluid stem cells

  2018cites this paper
• Developing a xenograft human tumor model in immunocompetent mice.

  2018cites this paper
• Long-Term Hematopoietic Engraftment of Congenic Amniotic Fluid Stem Cells After in Utero Intraperitoneal Transplantation to Immune Competent Mice

  2018cites this paper
• The effect of endothelial cell activation and hypoxia on placental chorionic mesenchymal stem/stromal cell migration.

  2017cites this paper
• Analysis of phenotype reversibility in Hutchinson-Gilford progeria syndrome in mice

  2017cites this paper
• Stem cells and fetal therapy: is it a reality?

  2017cites this paper
• In Utero Stem Cell Transplantation: Potential Therapeutic Application for Muscle Diseases

  2017cites this paper
• Clinical Applications of Stem Cells in Women’s Reproductive Health

  2017cites this paper
• Human Chorionic Stem Cells: Podocyte Differentiation and Potential for the Treatment of Alport Syndrome

  2016cites this paper
• Osteogenesis Imperfecta – A Case Series and Review of Recent Advances in Management

  2016cites this paper
• Animal models of osteogenesis imperfecta: applications in clinical research

  2016cites this paper
• Unique Features and Clinical Application Prospect of Human Umbilical Cord Mesenchymal Stem Cells

  2016cites this paper
• Raloxifene reduces skeletal fractures in an animal model of osteogenesis imperfecta.

  2016cites this paper
• Induced pluripotent stem (iPS) cells from human fetal stem cells.

  2016cites this paper
• Osteogenesis imperfecta: from diagnosis and multidisciplinary treatment to future perspectives.

  2016cites this paper
• Bone Material Properties in Osteogenesis Imperfecta

  2016cites this paper
• Human Foetal Mesenchymal Stem Cells.

  2016cites this paper
• Counteracting bone fragility with human amniotic mesenchymal stem cells

  2016cites this paper
• The biology and clinical applications of mesenchymal stromal cells derived from human gestational tissues

  2016cites this paper
• In utero stem cell transplantation and gene therapy: Recent progress and the potential for clinical application.

  2016cites this paper
• Bone repair with skeletal stem cells: rationale, progress to date and clinical application

  2016cites this paper
• Anhaftung multipotenter humaner mesenchymaler Stromazellen an spezifischen Peptiden : Studie zur Untersuchung von Zell-Zellmatrix-Interaktionen

  2015cites this paper
• Fetal and Perinatal Stem Cells in Regenerative Medicine

  2015cites this paper
• Treatment options for osteogenesis imperfecta

  2015cites this paper
• Target-antigen Detection and Localization of Human Amniotic-derived Cells after in Utero Transplantation in Rats.

  2015cites this paper
• Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies.

  2015cites this paper
• Intrauterine Bone Marrow Transplantation in Osteogenesis Imperfecta Mice Yields Donor Osteoclasts and Osteomacs but Not Osteoblasts

  2015cites this paper
• Stem cell transplantation before birth – a realistic option for treatment of osteogenesis imperfecta?

  2015cites this paper
• Engraftability of Murine Bone Marrow-Derived Multipotent Mesenchymal Stem Cell Subpopulations in the Tissues of Developing Mice following Systemic Transplantation

  2015cites this paper
• New frontiers for dominant osteogenesis imperfecta treatment: gene/cellular therapy approaches

  2015cites this paper
• Effect of adipose derived stem cells on ovariectomised Wistar rats

  2015cites this paper
• Engraftment of mouse amniotic fluid-derived progenitor cells after in utero transplantation in mice.

  2015cites this paper
• Intracellular trafficking and endocytosis of CXCR4 in fetal mesenchymal stem/stromal cells

  2014cites this paper
• Effect of Intra-Medullar and Intra-Venous Infusions of Mesenchymal Stem Cells on Cell Engraftment by In-Vivo Cell Tracking and Osteoinductivity in Rabbit Long Bones: A Pilot Study.

  2014cites this paper
• How Tough Is Brittle Bone? Investigating Osteogenesis Imperfecta in Mouse Bone

  2014cites this paper
• In utero therapy for congenital disorders using amniotic fluid stem cells

  2014influential citation
• In Utero Stem Cell and Gene Therapy: Current Status and Future Perspectives

  2014cites this paper
• Therapeutic application of mesenchymal stem cells in bone and joint diseases

  2014cites this paper
• Local transplantation is an effective method for cell delivery in the osteogenesis imperfecta murine model

  2014cites this paper
• Potential of Human Fetal Chorionic Stem Cells for the Treatment of Osteogenesis Imperfecta

  2014influential citation
• Pre‐ and Postnatal Transplantation of Fetal Mesenchymal Stem Cells in Osteogenesis Imperfecta: A Two‐Center Experience

  2014cites this paper
• Lack of blinding of outcome assessors in animal model experiments implies risk of observer bias.

  2014cites this paper
• Cell & Tissue Transplantation & Therapy Use of Adult Stem Cells for Orthopedic Regenerative Medicine Applications

  2014cites this paper
• Cell fusion phenomena detected after in utero transplantation of Ds‐red‐harboring porcine amniotic fluid stem cells into EGFP transgenic mice

  2014cites this paper
• Human Fetal and Adult Bone Marrow-Derived Mesenchymal Stem Cells Use Different Signaling Pathways for the Initiation of Chondrogenesis

  2014cites this paper
• Use of Adult Stem Cells for Orthopedic Regenerative Medicine Applications

  2014cites this paper
• Metabolische Erkrankungen in der Osteologie

  2014cites this paper
• Prenatal transplantation of mesenchymal stem cells to treat osteogenesis imperfecta

  2014cites this paper
• OSTEOGENESIS IMPERFECTA: DIAGNÓSTICO, TRATAMENTO E PROGNÓSTICO

  2013cites this paper
• Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs)

  2013cites this paper
• In Utero Stem Cell Transplantation for Radical Treatment of Osteogenesis Imperfecta: Perspectives and Controversies

  2013cites this paper
• Allele Dependent Silencing of Collagen Type I Using Small Interfering RNAs Targeting 3'UTR Indels - a Novel Therapeutic Approach in Osteogenesis Imperfecta

  2013cites this paper
• Gender-Dependence of Bone Structure and Properties in Adult Osteogenesis Imperfecta Murine Model

  2013cites this paper
• LNGFR+THY-1+VCAM-1hi+ Cells Reveal Functionally Distinct Subpopulations in Mesenchymal Stem Cells

  2013cites this paper